• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Cafepharma Playground

There is more to life than your job, so come to the Cafepharma Playground when you need a break and want to talk about whatever is on your mind. Registered posting only